CATHETER SITE PHLEBITIS

CATHETER SITE PHLEBITIS was reported 52 times

These drug classes are most commonly taken by patients reporting CATHETER SITE PHLEBITIS:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 9
1 Corticosteroid [EPC] 8
2 Opioid Agonist [EPC] 6
3 Proton Pump Inhibitor [EPC] 5
4 CD20-directed Cytolytic Antibody [EPC] 4
5 Thalidomide Analog [EPC] 4
6 Atypical Antipsychotic [EPC] 3
7 Benzodiazepine [EPC] 3
8 Dietary Cholesterol Absorption Inhibitor [EPC] 3
9 Thiazide Diuretic [EPC] 3
10 beta-Adrenergic Blocker [EPC] 3
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2
12 Epidermal Growth Factor Receptor Antagonist [EPC] 2
13 Glycopeptide Antibacterial [EPC] 2
14 Insulin Analog [EPC] 2
15 Loop Diuretic [EPC] 2
16 Osmotic Laxative [EPC] 2
17 Platinum-based Drug [EPC] 2
18 Potassium Salt [EPC] 2
19 Sulfonamide Antimicrobial [EPC] 2
20 Tumor Necrosis Factor Blocker [EPC] 2
21 Typical Antipsychotic [EPC] 2
22 Aldosterone Antagonist [EPC] 1
23 Alkylating Drug [EPC] 1
24 Aminoglycoside Antibacterial [EPC] 1
25 Androgen Receptor Inhibitor [EPC] 1
26 Angiotensin Converting Enzyme Inhibitor [EPC] 1
27 Anthelmintic [EPC] 1
28 Antimetabolite [EPC] 1
29 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1
30 CD52-directed Cytolytic Antibody [EPC] 1
31 Claudin 18.2-directed Cytolytic Antibody [EPC] 1
32 Complement Inhibitor [EPC] 1
33 Expectorant [EPC] 1
34 Factor Xa Inhibitor [EPC] 1
35 Folate Analog Metabolic Inhibitor [EPC] 1
36 Human Immunoglobulin G [EPC] 1
37 Integrin Receptor Antagonist [EPC] 1
38 Interferon beta [EPC] 1
39 Kinase Inhibitor [EPC] 1
40 Microtubule Inhibitor [EPC] 1
41 Nucleoside Metabolic Inhibitor [EPC] 1
42 Pediculicide [EPC] 1
43 Penem Antibacterial [EPC] 1
44 Platelet Aggregation Inhibitor [EPC] 1
45 Potassium Channel Blocker [EPC] 1
46 Prostacycline Vasodilator [EPC] 1
47 Proteasome Inhibitor [EPC] 1
48 Pyrimidine Synthesis Inhibitor [EPC] 1
49 SLAMF7-directed Immunostimulatory Antibody [EPC] 1
50 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
51 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1
52 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
53 Xanthine Oxidase Inhibitor [EPC] 1